Advancing hope for lung cancer patients
In a giant step toward improving the lives of lung cancer patients, in spring 2019 ChristianaCare’s Gene Editing Institute announced that it would seek approval from the U.S. Food and Drug Administration to advance a clinical trial using CRISPR genome editing to improve the effectiveness of chemotherapy for treating K-ras-positive non-small-cell lung cancer. The disease is resistant to chemotherapy, and this landmark research may help prevent resistance.
Wired care for our caregivers
As health care professionals, we understand that to be fully available to patients we must be physically and emotionally healthy ourselves. ChristianaCare’s new Virtual Primary Care Practice for our caregivers and their spouses enables them to connect with a health care provider via a smartphone, tablet or personal computer, 24 hours per day, 7 days a week instead of making in-person appointment in a doctor’s office. As of November 2019, the practice has seen more than 1,000 visits and sent more than 14,000 secure messages via the patient engagement platform Twistle.